MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines.Published in:Cancer Biology & Therapy, 2013, v. 14, n. 10, p. 932, doi. 10.4161/cbt.25939By:Almhanna, Khaldoun;Cubitt, Christopher L.;Zhang, Shumin;Kazim, Sabiha;Husain, Kazim;Sullivan, Dan;Sebti, Said;Malafa, MokengePublication type:Article